发明名称 |
Combination therapy using a tnf binding protein for treating tnf-mediated diseases |
摘要 |
The invention relates to methods for treating or preventing acute and/or septic shock. The method comprises administering to patients in need thereof therapeutically effective amounts of a TNF binding protein and a Fas antigen. In a preferred embodiment, the TNF binding protein is sTNFR-I or sTNFR-II. The invention also relates to pharmaceutical compositions containing a TNF binding protein and a Fas antigen useful in such methods. |
申请公布号 |
AU5696198(A) |
申请公布日期 |
1998.06.29 |
申请号 |
AU19980056961 |
申请日期 |
1997.12.08 |
申请人 |
AMGEN INC |
发明人 |
ALISON M. BENDELE;REGINA M. SENNELLO;CARL K. EDWARDS III |
分类号 |
A61K45/00;A61K31/519;A61K38/00;A61K38/17;A61P19/02;A61P29/00;A61P43/00;C07K14/525;(IPC1-7):A61K38/00;A61K31/00;C07K14/00 |
主分类号 |
A61K45/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|